Bedside Resources to Gauge Intravascular Volume Status

June 27, 2023 updated by: University of Colorado, Denver

Bedside Resources to Gauge Intravascular Volume Status in Hypovolemic Infants in the Operating Room

The goal if this study is to employ the CardioQ-Esophageal Aortic Doppler probe to define fluid responders from non-responders among infants undergoing cranial vault reconstruction for craniosynostosis. After defining these two groups in this single arm prospective trial, the investigators will compare the predictive utility of non-invasive devices such as the CipherOx-Compensatory Reserve Index (CipherOx-CRI) and Inferior Vena Cava Collapsibility Index (IVC CI) to currently employed indices (heart rate, systolic blood pressure, urine output and pulse pressure variability) to gauge the need for additional fluid and ongoing resuscitation. If the CipherOx-CRI or IVC CI proved to be as predictive or better at predicting fluid responders, the investigators hope to replace invasive arterial lines with non-invasive tools to guide resuscitation.

Study Overview

Status

Completed

Detailed Description

Predicting fluid responsiveness in the operating room is essential to guide balanced resuscitation. Aggressive resuscitation may lead to significant morbidities, such as intra-abdominal hypertension, pulmonary edema, difficulty with ventilator liberalization, and consequently increased mortality. Alternatively, under resuscitation may lead to mal-perfusion and end-organ dysfunction.

A plethora of indices and tools have been studied and marketed to assess intravascular volume status with only a few proven reliable with reproducible results. Based on pre-fluid challenge values, several of these tools have been used to predict who may benefit from additional fluid (fluid responders). Alternatively, some of these tools have been used to distinguish fluid responders from non-responders based on changes in pre- and post-fluid challenge values. Among these tools, the pulmonary artery catheter provides measurements of both left and right heart pressures which can be applied to calculate the cardiac output (CO) and stroke volume (SV). Changes in these values (e.g. an increase in the stroke volume by 10%) between pre- and post-fluid challenge have been used to define fluid responders. This devise, however, is invasive with several significant risks, and therefore is rarely used in children. Echocardiography, on the other hand, is a non-invasive bedside study also used to assess CO and SV but is expensive and requires trained echosonagraphers for application. Further, because a transthoracic probe is required to obtain the images, application in the operating room is difficult as the chest is often in the operating field limiting access to the echosonagrapher. Lastly, the esophageal aortic blood flow device (CardioQ-Esophageal Dopler Monitor (Cardio-EDM), Deltex Medical, Chichester, UK) has been found in multiple adult and pediatric studies to reliably distinguish fluid responders from non-responders intensive care unit (ICU) and operating room. Much like an orogastric tube, this device is simply placed by a provider in the patient's esophagus and uses Doppler waveforms to measure aortic blood flow velocities. Variations in the amplitude of peak velocities has been shown to corelate with intravascular volume status. Specifically, a change in the peak velocity by greater than 10% between pre- and post-fluid challenge values has been shown to accurately distinguishes those who are fluid responsive from those who are not with similar accuracy to echocardiography and pulmonary artery catheter readings.

In recent years with continued technological advancements, there has been enthusiasm about less invasive, and in some cases, non-invasive, tools to gauge volume status. Among these, bedside ultrasonography (performed by providers rather than sonographers) is a common tool used to evaluate the inferior vena cava (IVC) collapsibility index (CI) has been shown to be a reliable tool in adults. Another non-invasive device uses a photoplethysmoraphic probe (CipherOx-CRI) placed on a digit to calculate the compensatory reserve index (CRI), a marker of proximity to hemodynamic collapse. Both IVC CI and CRI have been shown in multiple adult studies to predictive the need for volume expansion, but their utility in the pediatric population is unknown.

The goal if this proposed study is to employ the CardioQ-EDM probe to define fluid responders from non-responders among infants undergoing cranial vault reconstruction for craniosynostosis. After defining these two groups in this single arm prospective trial, the investigators will compare the predictive utility of non-invasive devices such as the CipherOx-CRI and IVC CI to currently employed indices (heart rate, systolic blood pressure, urine output and pulse pressure variability) to gauge the need for additional fluid and ongoing resuscitation. If the CipherOx-CRI or IVC CI proved to be as predictive or better at predicting fluid responders, the investigators hope to replace invasive arterial lines with non-invasive tools to guide resuscitation.

The investigators chose this population for several reasons. First, the investigators institution performs approximately 50-70 of these cases a year making them a relatively accessible group. Second, these children are generally healthy which will minimize physiologic confounders. Additionally, the subjects are paralyzed, have normal respiratory compliance, and providers maintain normothermia, all of which will minimizing confounders. Another unique benefit to this population is that these infants have been nil per os for several hours prior to surgery, putting them at risk for hypovolemia, and after induction, independent of the provider's assessment of intravascular volume status, all children receive a bolus of crystalloid (10mL/kg). This baseline data should provide sufficient data for analysis; but because these procedures are associated with significant blood loss and hypovolemia requiring aggressive resuscitation in the form of fluid or blood boluses, the investigators plan to continue to collect pre- and post- bolus data with the hope to further validate the benefit of non-invasive tools such as the CipherOx-CRI and IVC CI in the setting of ongoing blood loss.

As intravascular volume status is often difficult to assess clinically, the investigators aim to determine the predictability of non-invasive devices to guide resuscitation. In this prospective observational study, the investigators hope to identify:

  1. The proportion of children within the cohort who are fluid responsive based on CardioQ-EDM aortic blood flow velocity changes pre- and post-bolus,
  2. The positive predictive value, negative predictive value, sensitivity, specificity, and optimal threshold for CRI, IVC CI, pulse pressure variability, stroke volume variability, heart rate, systolic blood pressure, and mean arterial pressures in predicting fluid responders as determined by CardioQ-EDM, and
  3. Assess confounding variables that may influence the predictive utility of such devices

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • Children's Hospital Colorado

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 months to 2 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Children with craniosynostosis undergoing cranial vault reconstruction

Exclusion Criteria:

  • Children with known underlying cardiac anomalies or cardiac arrhythmias
  • Weight less than 3 kg
  • Children who have vasopressors adjusted during a fluid bolus

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Fluid Challenge
After defining fluid responders from non-responders in this single arm prospective trial, we will compare the predictive utility of non-invasive devices such as the CipherOx-CRI and IVC CI to currently employed indices (heart rate, systolic blood pressure, urine output and pulse pressure variability) to gauge the need for additional fluid and ongoing resuscitation.
A CardioQ-EDM probe will be placed on the day of surgery after induction of general anesthesia. The anesthesiologist will inform the investigator of plans to provide a fluid or blood bolus per clinical judgement in addition to the protocolized 10 ml/kg bolus provided after induction. While the anesthesiologist is preparing to administer volume expansion, a co-investigator will collect pre-fluid bolus data. Measurements will be recorded for data analysis at the completion of the trial. Additionally, a CipherOx-CRI probe will be placed on the patient's index finger (recorded data will be interpreted post hoc) and a bedside ultrasound will be performed by either the principal investigator (PI) or one of two co-investigators to measure the IVC CI. Ultrasound cine-loops will be recorded, and CI will be calculated post-hoc. Data will be recorded on the Data Collection Form for each fluid bolus administered. The PI and co-investigators will manage all aspects of investigational devices.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Utility of Compensatory Reserve Index (CRI) Which Ranges From 0-1 in Order to Predict Fluid Responders From Non-responders
Time Frame: Through study completion (3-4 hours)

Using a delta peak aortic velocity threshold of 10% (measured from CardioQ-EDM) before and after a bolus to define fluid responders (=/>10%) from non-responders (<10%), we will determine the performance of pre-bolus CRI reading which is an index between 0 and 1 (0=poor reserve and 1=excellent reserve) in order to predict fluid responders from non-responders. Measurements will be recorded three times with one minute between measurements and then averaged.

Vital signs analyzed included heart rate, systolic blood pressure, mean arterial pressure, shock index (heart rate/systolic blood pressure), pulse pressure variability, and end-tidal carbon dioxide level. Infants were also monitored with a Compensatory Reserve Index (CRI) monitor, which provides a continuous, individual-specific, beat-to-beat estimate of central volume status, from normovolemia (CRI=1) to decompensation (CRI=0). Each variable's performance was compared using area under the receiver operator curves (AUC).

Through study completion (3-4 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate whether sex confounds the accuracy of each primary outcome in distinguishing fluid responders from non-responders.
Time Frame: Through study completion (3-4 hours)
Area under the curve will be calculated for the primary outcome variables using multiple logistic regression models including sex. Confounders will be identified for inclusion in the multiple logistic regression models by calculating the univariate association with the gold standard (using a p<0.10 threshold). These adjusted models will be used to verify thresholds for classification using the primary outcomes which will then be applied to calculate classification summary measures (e.g., positive predictive value, negative predictive value, sensitivity, and specificity).
Through study completion (3-4 hours)
Evaluate whether race confounds the accuracy of each primary outcome in distinguishing fluid responders from non-responders.
Time Frame: Through study completion (3-4 hours)
Area under the curve will be calculated for the primary outcome variables using multiple logistic regression models including race. Confounders will be identified for inclusion in the multiple logistic regression models by calculating the univariate association with the gold standard (using a p<0.10 threshold). These adjusted models will be used to verify thresholds for classification using the primary outcomes which will then be applied to calculate classification summary measures (e.g., positive predictive value, negative predictive value, sensitivity, and specificity).
Through study completion (3-4 hours)
Evaluate whether ethnicity confounds the accuracy of each primary outcome in distinguishing fluid responders from non-responders.
Time Frame: Through study completion (3-4 hours)
Area under the curve will be calculated for the primary outcome variables using multiple logistic regression models including ethnicity. Confounders will be identified for inclusion in the multiple logistic regression models by calculating the univariate association with the gold standard (using a p<0.10 threshold). These adjusted models will be used to verify thresholds for classification using the primary outcomes which will then be applied to calculate classification summary measures (e.g., positive predictive value, negative predictive value, sensitivity, and specificity).
Through study completion (3-4 hours)
Evaluate whether weight in kilograms confounds the accuracy of each primary outcome in distinguishing fluid responders from non-responders.
Time Frame: Through study completion (3-4 hours)
Area under the curve will be calculated for the primary outcome variables using multiple logistic regression models including weight. Confounders will be identified for inclusion in the multiple logistic regression models by calculating the univariate association with the gold standard (using a p<0.10 threshold). These adjusted models will be used to verify thresholds for classification using the primary outcomes which will then be applied to calculate classification summary measures (e.g., positive predictive value, negative predictive value, sensitivity, and specificity).
Through study completion (3-4 hours)
Evaluate whether height in centimeters confounds the accuracy of each primary outcome in distinguishing fluid responders from non-responders.
Time Frame: Through study completion (3-4 hours)
Area under the curve will be calculated for the primary outcome variables using multiple logistic regression models including heigh. Confounders will be identified for inclusion in the multiple logistic regression models by calculating the univariate association with the gold standard (using a p<0.10 threshold). These adjusted models will be used to verify thresholds for classification using the primary outcomes which will then be applied to calculate classification summary measures (e.g., positive predictive value, negative predictive value, sensitivity, and specificity).
Through study completion (3-4 hours)
Evaluate whether tidal volume in milliliters per kilogram confounds the accuracy of each primary outcome in distinguishing fluid responders from non-responders.
Time Frame: Through study completion (3-4 hours)
Area under the curve will be calculated for the primary outcome variables using multiple logistic regression models including tidal volume. Confounders will be identified for inclusion in the multiple logistic regression models by calculating the univariate association with the gold standard (using a p<0.10 threshold). These adjusted models will be used to verify thresholds for classification using the primary outcomes which will then be applied to calculate classification summary measures (e.g., positive predictive value, negative predictive value, sensitivity, and specificity).
Through study completion (3-4 hours)
Evaluate whether peak inspiratory pressure measured in centimeters of water confounds the accuracy of each primary outcome in distinguishing fluid responders from non-responders.
Time Frame: Through study completion (3-4 hours)
Area under the curve will be calculated for the primary outcome variables using multiple logistic regression models including peak inspiratory pressure. Confounders will be identified for inclusion in the multiple logistic regression models by calculating the univariate association with the gold standard (using a p<0.10 threshold). These adjusted models will be used to verify thresholds for classification using the primary outcomes which will then be applied to calculate classification summary measures (e.g., positive predictive value, negative predictive value, sensitivity, and specificity).
Through study completion (3-4 hours)
Evaluate whether peak end-expiratory pressure measured in centimeters of water confounds the accuracy of each primary outcome in distinguishing fluid responders from non-responders.
Time Frame: Through study completion (3-4 hours)
Area under the curve will be calculated for the primary outcome variables using multiple logistic regression models including peak end-expiratory pressure. Confounders will be identified for inclusion in the multiple logistic regression models by calculating the univariate association with the gold standard (using a p<0.10 threshold). These adjusted models will be used to verify thresholds for classification using the primary outcomes which will then be applied to calculate classification summary measures (e.g., positive predictive value, negative predictive value, sensitivity, and specificity).
Through study completion (3-4 hours)
Evaluate whether respiratory rate measured in breaths per minute confounds the accuracy of each primary outcome in distinguishing fluid responders from non-responders.
Time Frame: Through study completion (3-4 hours)
Area under the curve will be calculated for the primary outcome variables using multiple logistic regression models including respiratory rate. Confounders will be identified for inclusion in the multiple logistic regression models by calculating the univariate association with the gold standard (using a p<0.10 threshold). These adjusted models will be used to verify thresholds for classification using the primary outcomes which will then be applied to calculate classification summary measures (e.g., positive predictive value, negative predictive value, sensitivity, and specificity).
Through study completion (3-4 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sarkis Derderian, MD, Children's Hospital Colorado

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 8, 2019

Primary Completion (Actual)

March 12, 2020

Study Completion (Actual)

March 12, 2020

Study Registration Dates

First Submitted

April 8, 2019

First Submitted That Met QC Criteria

April 11, 2019

First Posted (Actual)

April 16, 2019

Study Record Updates

Last Update Posted (Actual)

June 29, 2023

Last Update Submitted That Met QC Criteria

June 27, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No plan to share individual participant data with other researchers is planned

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypovolemia

Clinical Trials on CardioQ-EDM and CipherOx-CRI

3
Subscribe